The table below shows REPLIGEN CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$738.26M
$634.44M
$632.36M
$801.54M
$670.53M
$366.26M
Cost of revenue
$352.01M
$359.79M
$353.92M
$345.83M
$279.28M
$156.63M
Gross profit
-
-
-
-
-
-
R&D
$54.18M
$43.20M
$42.72M
$43.94M
$34.27M
$20.18M
RGEN annual revenue (10-K history)
REPLIGEN CORP reported annual revenue of $738.26M for fiscal year 2025. That is up 16.4% from $634.44M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $104.54M (FY 2016) to $738.26M. Figures come from the company's audited annual reports as filed with the SEC.
